TP53 and lung carcinoma: It is worth mentioning that the study found that sophoridine can significantly activate the Hippo and p53 signaling pathways and inhibit the progression of lung cancer and enhance the effect of the anticancer drug cisplatin against lung cancer cells (Zhu et al., 2020).